Dupilumab: a potential new treatment for severe asthma
Lancet
.
2016 Jul 2;388(10039):3-4.
doi: 10.1016/S0140-6736(16)30311-7.
Epub 2016 Apr 27.
Author
Kian Fan Chung
1
Affiliation
1
Experimental Studies Unit, National Heart & Lung Institute, Imperial College London, UK; Biomedical Research Unit, Royal Brompton & Harefield NHS Trust, London SW3 6LY, UK. Electronic address: f.chung@imperial.ac.uk.
PMID:
27130690
DOI:
10.1016/S0140-6736(16)30311-7
No abstract available
Publication types
Comment
MeSH terms
Anti-Asthmatic Agents / administration & dosage*
Antibodies, Monoclonal / administration & dosage*
Asthma / drug therapy*
Female
Humans
Male
Substances
Anti-Asthmatic Agents
Antibodies, Monoclonal